Page 217 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Classification and Pathogenicity of ANCA-Associated Vasculitis 193

[67] Gilligan, H. M., Bredy, B., Brady, H. R., et al. Antineutrophil cytoplasmic
autoantibodies interact with primary granule constituents on the surface of apoptotic
neutrophils in the absence of neutrophil priming. J. Exp. Med. 1996; 184:2231-2241.

[68] Csernok, E., Lamprecht, P., Gross, W. L. Clinical and immunological features of drug-
induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and
myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr. Opin.
Rheumatol. 2010; 22:43-48.

[69] Rao, J. K., Weinberger, M., Oddone, E. Z., et al. The role of antineutrophil cytoplasmic
antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature
review and meta-analysis. Ann. Intern. Med. 1995; 123:925-932.

[70] Hagen, E. C., Daha, M. R., Hermans, J., et al. Diagnostic value of standardized assays
for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR
Project for ANCA Assay Standardization. Kidney Int. 1998; 53:743-753.

[71] Bansal, P. J., Tobin, M. C. Neonatal microscopic polyangiitis secondary to transfer of
maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal
pulmonary hemorrhage and renal involvement. Ann. Allergy Asthma Immunol. 2004;
93: 398-401.

[72] Marinaki, S., Kalsch, A. I., Grimminger, P., et al. Persistent T-cell activation and
clinical correlations in patients with ANCA-associated systemic vasculitis. Nephrol.
Dial. Transplant. 2006; 21:1825-1832.

[73] Falk, R. J., Nachman, P. H., Hogan, S. L., et al. ANCA glomerulonephritis and
vasculitis: a Chapel Hill perspective. Semin. Nephrol. 2000; 20:233-243.

[74] Savage, C. O. ANCA-associated renal vasculitis. Kidney Int. 2001; 60:1614-1627.
[75] Specks, U., Fass, D. N., Finkielman, J. D., et al. Functional significance of Asn-linked

glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and
recognition by anti-neutrophil cytoplasmic antibodies. J. Biochem. 2007; 141:101-112.
[76] Tomasson, G., Grayson, P. C., Mahr, A. D., et al. Value of ANCA measurements
during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.
Rheumatology 2012; 51:100-109.
[77] Holland, M., Hewins, P., Goodall, M., et al. Anti-neutrophil cytoplasm antibody IgG
subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4
subclass. Clin. Exp. Immunol. 2004; 138:183-192.
[78] Holland, M., Yagi, H., Takahashi, N., et al. Differential glycosylation of polyclonal
IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated
systemic vasculitis. Biochim. Biophys. Acta 2006; 1760:669-677.
[79] Holland, M., Takada, K., Okumoto, T., Takahashi, N., Kato, K., Adu, D., Ben-Smith,
A., Harper, L., Savage, C. O., Jefferis, R. Hypogalactosylation of serum IgG in patients
with ANCA-associated systemic vasculitis. Clin. Exp. Immunol. 2002; 129:183-190.
[80] Pfister, H., Ollert, M., Frohlich, L. F., et al. Antineutrophil cytoplasmic autoantibodies
against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in
vivo. Blood 2004; 104:1411-1418.
[81] Xiao, H., Heeringa, P., Hu, P., et al. Antineutrophil cytoplasmic autoantibodies specific
for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest.
2002; 110: 955-963.

Complimentary Contributor Copy